TD Private Client Wealth LLC Has $134,000 Stock Position in Bath & Body Works, Inc. $BBWI

TD Private Client Wealth LLC lifted its stake in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 34.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,460 shares of the company’s stock after purchasing an additional 1,155 shares during the quarter. TD Private Client Wealth LLC’s holdings in Bath & Body Works were worth $134,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. T. Rowe Price Investment Management Inc. boosted its holdings in Bath & Body Works by 7.6% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 11,016,767 shares of the company’s stock worth $334,029,000 after buying an additional 781,681 shares during the period. Victory Capital Management Inc. boosted its stake in shares of Bath & Body Works by 14,732.0% during the 1st quarter. Victory Capital Management Inc. now owns 6,798,108 shares of the company’s stock valued at $206,119,000 after purchasing an additional 6,752,274 shares in the last quarter. Alliancebernstein L.P. boosted its stake in shares of Bath & Body Works by 4.7% during the 1st quarter. Alliancebernstein L.P. now owns 5,422,058 shares of the company’s stock valued at $164,397,000 after purchasing an additional 243,611 shares in the last quarter. AQR Capital Management LLC boosted its stake in shares of Bath & Body Works by 267.8% during the 1st quarter. AQR Capital Management LLC now owns 3,993,173 shares of the company’s stock valued at $121,073,000 after purchasing an additional 2,907,506 shares in the last quarter. Finally, GMT Capital Corp boosted its stake in Bath & Body Works by 7.3% during the first quarter. GMT Capital Corp now owns 3,737,700 shares of the company’s stock worth $113,327,000 after acquiring an additional 255,600 shares in the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Stock Performance

Shares of BBWI opened at $26.05 on Tuesday. The company’s 50-day simple moving average is $28.94 and its 200-day simple moving average is $29.58. The stock has a market capitalization of $5.37 billion, a PE ratio of 7.73, a P/E/G ratio of 0.91 and a beta of 1.49. Bath & Body Works, Inc. has a 1 year low of $24.93 and a 1 year high of $41.87.

Bath & Body Works (NYSE:BBWI) last announced its earnings results on Thursday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.37. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The business had revenue of $1.55 billion for the quarter, compared to analyst estimates of $1.55 billion. During the same period last year, the firm posted $0.37 earnings per share. The company’s revenue for the quarter was down .8% compared to the same quarter last year. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. On average, sell-side analysts predict that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, September 5th. Stockholders of record on Friday, August 22nd were issued a dividend of $0.20 per share. The ex-dividend date was Friday, August 22nd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 3.1%. Bath & Body Works’s payout ratio is presently 23.74%.

Analyst Ratings Changes

Several research analysts have recently weighed in on BBWI shares. UBS Group decreased their price objective on shares of Bath & Body Works from $36.00 to $32.00 and set a “neutral” rating for the company in a report on Friday, August 29th. Wall Street Zen lowered shares of Bath & Body Works from a “buy” rating to a “hold” rating in a research report on Saturday, August 9th. Barclays raised their target price on shares of Bath & Body Works from $30.00 to $32.00 and gave the company an “equal weight” rating in a research note on Friday, August 29th. Morgan Stanley cut their target price on shares of Bath & Body Works from $19.00 to $18.00 and set an “overweight” rating for the company in a research note on Friday, September 12th. Finally, Telsey Advisory Group reiterated an “outperform” rating and set a $38.00 price objective on shares of Bath & Body Works in a research report on Thursday, August 28th. Twelve investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $39.69.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.